Navigation Links
Covance Reports Second Quarter Net Revenue of $592 Million, Pro Forma EPS of $0.78 and Record Adjusted Net Orders of $776 Million
Date:7/30/2013

PRINCETON, N.J., July 30, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today reported results for its second quarter ended June 30, 2013.  Net revenue was $592.3 million, representing 9.1% growth from the second quarter of 2012's GAAP result of $542.8 million, and 10.0% growth from the second quarter of 2012's pro forma result of $538.5 million.  On a GAAP basis, the company reported earnings of $0.72 per diluted share in the second quarter.  Excluding charges associated with restructuring and other cost reduction actions totaling $6.0 million and a gain on the sale of an equity investment of $0.7 million, the company reported earnings per diluted share of $0.78, up 19.9% over the pro forma earnings of $0.65 for the second quarter of 2012. 

"Accelerated revenue growth in central laboratories was the primary driver of better-than-expected consolidated results in the second quarter, including pro forma revenue growth of 10%, operating margin of 9.7%, and EPS growth of 20% to $0.78," said Joe Herring, Chairman and Chief Executive Officer. "Strong commercial performance, led by clinical development, delivered record adjusted net orders of $776 million in the quarter. These orders result in an adjusted net book-to-bill of 1.31 to 1.  

"Late-Stage Development second quarter revenue grew 17% year-on-year to $378 million and pro forma operating margins were 21.4%, up 30 basis points from a year ago despite increased spending on strategic IT projects.  Better-than-expected kit volumes in central laboratories drove both year-over-year revenue growth of 22% and operating margin expansion.  Clinical development grew revenue 13% year-on-year and delivered record adjusted net orders.

"In Early Development, revenue of $215 million was flat from last year's pro forma result as strong revenue growth in nutritional chemistry and clinical p
'/>"/>

SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance Central Laboratory Services Again Ranks #1 in Global Investigator Satisfaction Survey
2. Covance To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
3. Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
4. Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients Increased Asia Pacific Focus
5. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2013 Financial Results Conference Call
6. Covance To Present At The Citi 2013 Global Healthcare Conference
7. Covance To Present At The Leerink Swann Global Healthcare Conference
8. Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
9. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
10. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
11. Covance to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... and SHANGHAI , Sept. ... (BHG), a global knowledge leader in healthcare technology, ... to support healthcare innovation in China ... connected health technologies. Continua and BHG announced this ... being held this week in Washington, ...
(Date:9/22/2014)... , Sept. 22, 2014  Aethlon Medical, ... therapeutic devices to address infectious disease, cancer and ... Advanced Research Projects Agency (DARPA) has informed the ... to proceed with year four of a five-year ... on September 30, 2011 under DARPA,s Dialysis-Like Therapeutics ...
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3
... Calif., Oct. 25 Applied Seals North ... products used in ultraclean manufacturing of nanoelectronics and ... capabilities at its Silicon Valley headquarters with the ... Chen joins the company,s product engineering team to ...
... EAST BRUNSWICK, N.J., Oct. 25 Savient Pharmaceuticals, Inc. (Nasdaq: ... process to identify, following the approval of KRYSTEXXA™ by the ... the sale of the Company did not result in a ... directors will continue to evaluate strategic alternatives available to the ...
Cached Medicine Technology:Applied Seals North America Bolsters Engineering and Applications Services in Silicon Valley With Addition of Design Engineer 2Savient Pharmaceuticals Provides Update on Strategic Alternatives Process 2Savient Pharmaceuticals Provides Update on Strategic Alternatives Process 3
(Date:9/23/2014)... 23, 2014 Névo takes a bold ... timepiece and adding advanced activity tracking and phone notifications ... steps, distance, calories burned, and more. , http://www.nevowatch.com ... adopt healthy habits in their busy lives to look ... changes that produce healthy results, but until now, style ...
(Date:9/23/2014)... Texas (PRWEB) September 23, 2014 Dallas-based luxury ... the appointment of Leslie Eades as vice president of product ... brand as well as the primary lead on global sourcing ... the head of both the product development group and sourcing ... development team. , Eades notes, "Peacock Alley is a ...
(Date:9/23/2014)... Recently, BuyTopDress.com, a popular supplier of wedding dresses and special ... fashionable marine ball dresses . Along with this, the ... brand new items; all of them are now provided with ... now, BuyTopDress.com has won more than 2000 happy customers in ... its products and after-sale services. The company is offering thousands ...
(Date:9/22/2014)... 2014 Vida Cannabis Corp . ... Alliance Agreement with Florida-based AltMed LLC . ... assurance, and technical expertise. They’ll also pool business ... respective markets. , "We’re deeply impressed with the ... Vida Cannabis team as they work toward building the ...
(Date:9/22/2014)... 23, 2014 Career Step, an ... will be attending and exhibiting at the 86th ... Information Management Association (AHIMA) in San Diego, California. ... October 1, and Career Step will be exhibiting ... of coding training products, including CLiM™, its coder ...
Breaking Medicine News(10 mins):Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3Health News:Luxury Linen Purveyor Peacock Alley Announces New Vice President of Product Development 2Health News:Fashionable Marine Ball Dresses Added To BuyTopDress.com’s Collection 2Health News:Vida Cannabis Allies with Florida Medical Cannabis Leader AltMed to Build Best-in-Class Expertise 2Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2
... International Retail Expansion, With Near Term Focus on Top ... ExtensionIRVINE, Calif., Jan. 21 University Medical ... and efficacy-based skin and beauty care products sold at ... U.S., announced today that it has appointed Tom Roche ...
... following statement can be attributed to Michael J. ... consistently said two things: We are not inherently ... we have urged public policy makers to think ... without conditions, because without conditions the merger would ...
... 21 Omnicell, Inc. (Nasdaq: OMCL ), a leading provider ... 29 to discuss the Company,s fourth quarter 2008 financial results. , ... webcast, ... Who: Randall Lipps, chairman, president and chief executive officer, ...
... (Nasdaq: IDXX ), has scheduled the release of ... January 30, at approximately 7:00 a.m. (eastern). The Company will ... on that day. Individuals can access a live Webcast of ... site, www.idexx.com . An archived edition of the call ...
... Carolina researchers say it could detect virus that can ... -- A new urine test that can detect a ... to better diagnosis and treatment of patients with polyomavirus ... patients. , Polyomaviruses are harmless to healthy adults ...
... -- Schizophrenia may blur the boundary between internal and ... involved in self-reflection, and thus causing an exaggerated focus ... study has found. , The traditional view of ... that characterize the disease are caused by disconnections among ...
Cached Medicine News:Health News:University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing 2Health News:University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing 3Health News:Capital Blue Cross Issues Statement on Withdrawal of Merger 2Health News:Omnicell to Release Fourth Quarter 2008 Earnings Results on January 29 2Health News:New Test May Help Kidney Transplant Patients 2Health News:Altered brain activity in schizophrenia may cause exaggerated focus on self 2Health News:Altered brain activity in schizophrenia may cause exaggerated focus on self 3
... The UrinQuick Urine Chemistry Analyzer is ... analysis of urine test strips. The UrinQuick ... for QuickVue UrinChek 10+ SG and QuickVue ... analyzes the urine test strips by reflectance ...
... a qualitative assay for rapid detection of Strep ... Strep A test excels at detection of Strep ... colonization samples. This CLIA Waived test uses a ... Strep A leaves little chance for misdiagnosis, minimizing ...
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
...
Medicine Products: